Early signals of Inflation Reduction Act impact on small-molecule versus biologic post-approval oncology trials. - KIVIRID

Early signals of Inflation Reduction Act impact on small-molecule versus biologic post-approval oncology trials.

Authors: Hanke Zheng, Julie Patterson, Jonathan D. Campbell

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.11032

Source: Full article

Abstract

11032